Wutah dodolan YoY sajrone rolas wulan kepungkur: KALA BIO, Inc. (KALA)

Tandha merek kalarx.com (KALA)

KALA BIO, Inc. (KALA) is developing innovative corneal therapies utilizing a unique drug delivery method. The year-over-year sales growth rate over the trailing four quarters reflects revenue dynamics, where 0.00 shows the current value of the metric. Business efficiency is supported by the outsourcing of production and logistics, while the implementation of laboratory robotics accelerates the preclinical screening of new ophthalmological biologics.

KALA KALA BIO, Inc.: Wutah pendapatan YoY sajrone 12 wulan kepungkur ing interval 11.02.2024 - 18.11.2026

kalarx.com (KALA) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:KALA BIO, Inc.
Produk sing diprodhuksi KALA BIO, Inc.

This indicator measures rolling year revenue dynamics, smoothing out short-term fluctuations to identify the true pace of business scaling. Analyzing the percentage change in sales over the last 12 months compared to the previous 12 months allows for an assessment of how effectively the diversification of stem cell-based ophthalmological developments at KALA BIO, Inc. (KALA) converts into financial growth, determining the long-term potential of the asset's investment attractiveness.